Sylvia Hsu

TL;DR: Treatment recommendations to aid in the treatment of patients with pustular psoriasis depends on the severity of presentation and patient's underlying risk factors, and the data are extremely limited for this type of Psoriasis.

TL;DR: Screening patients for latent TB infection before commencement of treatment is of utmost importance when beginning treatment with the tumor necrosis factor-alpha inhibitors, T-cell blockers, cyclosporine, or methotrexate.

TL;DR: In this article, the failure of omalizumab to improve atopic dermatitis in 3 patients when administered for 4 months was reported, and the failure was attributed to elevated levels of IgE.

TL;DR: In the updated guidelines, sections on children, pregnant patients or pregnant partners of patients, nursing mothers, the elderly, patients with hepatitis B or C virus infections, human immunodeficiency virus-infected patients, and patients with malignant neoplasms are included, as well as sections on tumor necrosis factor blockers, elective surgery, and vaccinations.

TL;DR: Some therapies for moderate to severe psoriasis, including methotrexate and tumor necrosis factor inhibitors, may reduce cardiovascular events in psoriatic patients, and ustekinumab appears to be neutral but there may be a long-term benefit.